Psychedelic drug ibogaine shows preliminary promise for ...
Psychedelic drug ibogaine shows preliminary promise for traumatic brain injury: Study
www.goodmorningamerica.comIbogaine is being studied for potential effects on addiction and mood/trauma symptoms, but researchers still don’t fully agree on a single “how it works” pathway. Recent science is converging on two themes: (1) it influences neurotransmitter systems involved in mood and reward (notably serotonin signaling), and (2) it may change brain network dynamics and neuroplasticity in ways that relate to PTSD/TBI outcomes—while safety concerns (especially heart rhythm risks) remain a major issue.
Ibogaine is widely discussed as powerful, but it also has serious risk concerns (including potential heart rhythm effects), which is why research protocols often emphasize medical supervision and protective strategies (like magnesium) and why use outside clinical/regulated settings is widely discouraged.[1]
If you tell me what you’re most curious about—addiction, PTSD/TBI, or depression—I can summarize the most relevant mechanism(s) and the newest findings for that specific area.
Psychedelic drug ibogaine shows preliminary promise for traumatic brain injury: Study
www.goodmorningamerica.comVeterans and others who have suffered trauma and injuries are flocking to clinics around the world to take ibogaine. My own reason was deeply personal.
www.nytimes.comA traditional African psychedelic plant medicine called ibogaine is the blueprint for two new drug candidates that could treat addiction and depression.
www.ucsf.eduStanford Medicine researchers find that ibogaine, a plant-based psychoactive compound, safely led to improvements in depression, anxiety and functioning among veterans with traumatic brain injuries.
med.stanford.eduSet on the Bahamas sand in a tropical oasis overlooking the vast turquoise ocean you will find The Avante Institute; a quiet but luxurious Iboga ...
www.newswire.comA non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers at the University of California, Davis. A paper describing the work is published Dec. 9 in Nature. “Psychedelics are some of the most powerful drugs we know of that affect the brain,” said David Olson, assistant professor of chemistry at UC Davis and senior author on the paper. “It’s unbelievable how little we know...
www.ucdavis.eduPsychedelic drug ibogaine shows preliminary promise for traumatic brain injury: Study
abcnews.go.com